FindTrial
Sign In

Whole tumor histogram analysis of multiple diffusion metrics for glioma genotyping

Whole tumor histogram analysis of multiple diffusion metrics for glioma genotyping

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100048119
Enrollment
Unknown
Registered
2021-07-02
Start date
2018-12-01
Completion date
Unknown
Last updated
2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glioma

Interventions

Gold Standard:Confirmed by surgery or biopsy pathology
Index test:IDH,1P19Q,KI67

Sponsors

Department of MRI, The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 75 Years

Inclusion criteria

Inclusion criteria: Proved to be glioma WHO grade 2-4

Exclusion criteria

Exclusion criteria: WHO I gliomas, ependymomas, metastases, and other nonglial brain tumors

Design outcomes

Primary

MeasureTime frame
DTI;DKI;NODDI;MAP;Histogram;SEN, SPE, ACC, AUC of ROC;—

Countries

China

Contacts

Public ContactJingliang Cheng

Department of MRI, The First Affiliated Hospital of Zhengzhou University

fccchengjl@zzu.edu.cn+86 13603863860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026